Mitochondrial dysfunction has divergent, cell type-dependent effects on insulin action

Molecular Metabolism

Volumn 3, Issue 4, 2014, Pages 408-418

  Martin, Sheree D ^a   Morrison, Shona ^a   Konstantopoulos, Nicky ^a   McGee, Sean L ^a,b  

^a DEAKIN UNIVERSITY   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Adipocyte; Hepatocyte; Insulin action; Mitochondria; Reactive oxygen species

Indexed keywords

INSULIN; ISOPHANE INSULIN; LACTATE DEHYDROGENASE; OLIGOMYCIN; PHENFORMIN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; REACTIVE OXYGEN METABOLITE; ROSIGLITAZONE; ROTENONE;

ADIPOCYTE; ANIMAL CELL; ARTICLE; BIOENERGY; CELL FUNCTION; CELL RESPIRATION; CELL SPECIFICITY; CELL VIABILITY; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME INHIBITION; ENZYME RELEASE; GLUCOSE TRANSPORT; HORMONE ACTION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIVER CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN METABOLISM; SIGNAL TRANSDUCTION;

EID: 84902313581     PISSN: 22128778     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmet.2014.02.001     Document Type: Article

References (37)

1. Johnson D.A., Olefsky J.M. Origins and drivers of insulin resistance. Cell 2013, 152:673-684.
2. Brand M.D., Nicholls D.G. Assessing mitochondrial dysfunction in cells. Biochemical Journal 2011, 435:297-312.
3. Kelley D.E., He J., Menshikova E.V., Ritov V.B. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 2002, 51:2944-2950.
4. Phielix E., Schrauwen-Hinderling V.B., Mensink M., Lenaers E., Meex R., Hoeks J., et al. Lower intrinsic ADP-stimulated mitochondrial respiration underlies invivo mitochondrial dysfunction in muscle of male type 2 diabetic patients. Diabetes 2005, 57:2943-2949.
5. Ritov V.B., Menshikova E.V., He J., Ferrell R.E., Goodpaster B.H., Kelley D.E. Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes. Diabetes 2005, 54:8-14.
6. van Tienen F.H., Praet S.F., de Feyter M.H., van den Broek N.M., Lindsey P.J., Schoonderwoerd K.G., et al. Physical activity is the key determinant of skeletal muscle mitochondrial function in type 2 diabetes. Journal of Clinical Endocrinology and Metabolism 2012, 97:3261-3269.
7. Szendroedi J., Chmelik M., Schmid A.I., Nowotny P., Brehm A., Krssak M., et al. Abnormal hepatic energy homeostasis in type 2 diabetes. Hepatology 2009, 50:1079-1086.
8. Schmid A.I., Szendroedi J., Chmelik M., Krššak M., Moser E., Roden M. Liver ATP synthesis is lower and relates to insulin sensitivity in patients with type 2 diabetes. Diabetes Care 2011, 34:448-453.
9. Bouderba S., Sanz M.N., Sánchez-Martín C., El-Mir M.Y., Villanueva G.R., Detaille D., et al. Hepatic mitochondrial alterations and increased oxidative stress in nutritional diabetes-prone Psammomys obesus model. Experimental Diabetes Research 2012, 2012:430176.
10. Bogacka I., Xie H., Bray G.A., Smith S.R. Pioglitazone induces mitochondrial biogenesis in human subcutaneous adipose tissue invivo. Diabetes 2005, 54:1392-1399.
11. Choo H.J., Kim J.H., Kwon O.B., Lee C.S., Mun J.Y., Han S.S., et al. Mitochondria are impaired in the adipocytes of type 2 diabetic mice. Diabetologia 2006, 49:784-791.
12. Mitrou P., Boutati E., Lambadiari V., Maratou E., Papakonstantinou A., Komesidou V., et al. Rates of glucose uptake in adipose tissue and muscle invivo after a mixed meal in women with morbid obesity. Journal of Clinical Endocrinology and Metabolism 2009, 94:2958-2961.
13. Petersen K.,F., Dufour S., Befroy D.E., Garcia R., Shulman G.I. Impaired mitochondrial activity in the insulin-resistant offspring of patientswith type 2 diabetes. New England Journal of Medicine 2004, 350:664-671.
14. Reardon W., Ross R.J., Sweeney M.G., Luxon L.M., Pembrey M.E., Harding A.E., et al. Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA. Lancet 1992, 340:1376-1379.
15. Becker R., Laube H., Linn T., Damian M.S. Insulin resistance in patients with the mitochondrial tRNA(Leu(UUR)) gene mutation at position 3243. Experimental and Clinical Endocrinology and Diabetes 2002, 110:291-297.
16. Szendroedi J., Schmid A.I., Meyerspeer M., Cervin C., Kacerovsky M., Smekal G., et al. Impaired mitochondrial function and insulin resistance of skeletal muscle in mitochondrial diabetes. Diabetes Care 2009, 32:677-679.
17. Lowell B.B., Shulman G.I. Mitochondrial dysfunction and type 2 diabetes. Science 2005, 307:384-387.
18. Morino K., Petersen K.F., Dufour S., Befroy D., Frattini J., Shatzkes N., et al. Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. Journal of Clinical Investigation 2005, 115:3587-3593.
19. 2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. Journal of Clinical Investigation 2009, 119:573-581.
20. Hoehn K.L., Salmon A.B., Hohnen-Behrens C., Turner N., Hoy A.J., Maghzal G.J., et al. Insulin resistance is a cellular antioxidant defence mechanism. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:17787-17792.
21. Han D.H., Hancock C.R., Jung S.R., Higashida K., Kim S.H., Holloszy J.O. Deficiency of the mitochondrial electron transport chain in muscle does not cause insulin resistance. PLoS One 2011, 6:e19739.
22. Pospisilik J.A., Knauf C., Joza N., Benit P., Orthofer M., Cani P.D., et al. Targeted deletion of AIF decreases mitochondrial oxidativephosphorylation and protects from obesity and diabetes. Cell 2007, 131:476-491.
23. Quintens R., Singh S., Lemaire K., De Bock K., Granvik M., Schraenen A., et al. Mice deficient in the respiratory chain gene Cox6a2 are protected against high-fat diet-induced obesity and insulin resistance. PLoS One 2013, 8:e56719.
24. Owen M.R., Doran E., Halestrap A.P. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochemical Journal 2000, 348:607-614.
25. Sanz M.N., Sánchez-Martín C., Detaille D., Vial G., Rigoulet M., El-Mir M.Y., et al. Acute mitochondrial actions of glitazones on the liver: a crucial parameter for their antidiabetic properties. Cellular Physiology and Biochemistry 2011, 28:899-910.
26. Divakaruni A.S., Wiley S.E., Rogers G.W., Andreyev A.Y., Petrosyan S., Loviscach M., et al. Thiazolidinediones are acute, specific inhibitors of the mitochondrial pyruvate carrier. Proceedings of the National Academy of Sciences of the United States of America 2013, 110:5422-5427.
27. 2 emission without affecting respiratory capacity in skeletal muscle of obese rats. Free Radical Biology and Medicine 2010, 149:1082-1087.
28. Deschatrette J., Weiss M.C. Characterisation of differentiated and dedifferentiated clones from a rat hepatoma. Biochimie 1974, 56:1603-1611.
29. McGee S.L., Sadli N., Morrison S., Swinton C., Suphioglu C. DHA protects against zinc mediated alterations in neuronal cellular bioenergetics. Cellular Physiology and Biochemistry 2011, 28:57-162.
30. Brehm A., Krssak M., Schmid A.I., Nowotny P., Waldhausl W., Roden M. Increased lipid availability impairs insulin-stimulated ATP synthesis in human skeletal muscle. Diabetes 2006, 55:136-140.
31. Hoeks J., van Herpen N.A., Mensink M., Moonen-Kornips E., van Beurden D., Hesselink M.K., et al. Prolonged fasting identifies skeletal muscle mitochondrial dysfunction as consequence rather than cause of human insulin resistance. Diabetes 2010, 59:2117-2125.
32. Houstis N., Rosen E.D., Lander E.S. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006, 440:944-948.
33. Loh K., Deng H., Fukushima A., Cai X., Boivin B., Galic S., et al. Reactive oxygen species enhance insulin sensitivity. Cell Metabolism 2009, 10:260-272.
34. Yip M.F., Ramm G., Larance M., Hoehn K.L., Wagner M.C., Guilhaus M., et al. CaMKII-mediated phosphorylation of the myosin motor Myo1c is required for insulin-stimulated GLUT4 translocation in adipocytes. Cell Metabolism 2008, 8:384-398.
35. Miller R.A., Chu Q., Xie J., Foretz M., Viollet B., Birnbaum M.J. Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP. Nature 2013, 494:256-260.
36. Foretz M., Hébrard S., Leclerc J., Zarrinpashneh E., Soty M., Mithieux G., et al. Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state. Journal of Clinical Investigation 2010, 120:2355-2369.
37. Reginato M.J., Lazar M.A. Mechanisms by which thiazolidinediones enhance insulin action. Trends in Endocrinology and Metabolism 1999, 10:9-13.